Inveltys

Active Ingredient(s): Loteprednol Etabonate
FDA Approved: * August 22, 2018
Pharm Company: * KALA PHARMS INC
Category: Allergies, Cough & Cold

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Inveltys Overview

Loteprednol (as the ester loteprednol etabonate) is a corticosteroid used to treat inflammations of the eye. It is marketed by Bausch and Lomb as Lotemax[1] and Loterex. It was patented in 1980 and approved for medical use in 1998.[2] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Pharmacology 5.1 Mechanism of action 5.2 Pharmacokinetics 5.3 Retrometabolic drug design 6 Chemistry 6.1 Chemical synthesis 7 References 8 Furt...

Read more Inveltys Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Loteprednol

Recent Inveltys Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Loteprednol Etabonate

Gel: 0.38%, 0.5%
Ointment: 0.5%
Suspension: 0.2%, 0.5%
Suspension/drops: 0.2%, 0.20%, 0.5%, 0.50%, 1%

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Inveltys: (1 result)

Sorted by National Drug Code

71571-121 Inveltys 10 mg/ml Topical Suspension by Kala Pharmaceuticals, Inc.

Other drugs which contain Loteprednol Etabonate or a similar ingredient: (4 results)

ALREX Loteprednol1 discussion
LOTEMAX Loteprednol1 discussion
LOTEMAX SM Loteprednol Etabonate
LOTEPREDNOL